| |
| |
|
| Insider
Information: |
Lee Kenneth B Jr |
| Relationship: |
|
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
370,056 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$340,271 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
370,056 |
|
|
| Total
Value |
$340,271 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
1
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
3
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -24.9%
|
-36.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
POZEN Inc |
POZN |
Director |
2015-06-10 |
58,027 |
2007-06-13 |
0 |
Premium* |
|
|
CV Therapeutics Inc |
CVTX |
Director |
2009-04-03 |
11,670 |
2009-04-03 |
0 |
Premium* |
|
|
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
64,000 |
2009-09-22 |
0 |
Premium* |
|
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2023-06-13 |
68,863 |
2014-03-06 |
0 |
Premium* |
|
|
Aralez Pharmaceuticals Inc. |
ARLZ |
Director |
2017-05-11 |
102,952 |
2016-02-05 |
0 |
Premium* |
|
|
Eyenovia Inc |
EYEN |
|
2022-06-16 |
64,544 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
16,745 |
68,863 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2023-01-31 |
4 |
OE |
$1.71 |
$25,650 |
D/D |
15,000 |
52,118 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
|
– • – |
2022-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
22,222 |
64,544 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
|
– • – |
2022-05-19 |
4 |
B |
$2.20 |
$22,000 |
D/D |
10,000 |
42,322 |
0.01 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2021-09-13 |
4 |
S |
$15.35 |
$92,100 |
D/D |
(6,000) |
24,252 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2021-09-13 |
4 |
OE |
$3.22 |
$48,300 |
D/D |
15,000 |
30,252 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2021-06-15 |
4 |
B |
$5.41 |
$10,812 |
D/D |
2,000 |
25,359 |
2.39 |
% |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2021-06-14 |
4 |
B |
$5.47 |
$10,940 |
D/D |
2,000 |
23,359 |
2.39 |
% |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2021-06-11 |
4 |
B |
$5.38 |
$10,760 |
D/D |
2,000 |
21,359 |
2.39 |
% |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2020-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,288 |
19,359 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2019-11-18 |
4 |
B |
$1.45 |
$7,250 |
D/D |
5,000 |
15,252 |
2.39 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2019-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,038 |
12,071 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2018-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,033 |
4,033 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2017-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
102,952 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2017-03-15 |
4 |
B |
$2.52 |
$12,619 |
D/D |
5,000 |
95,452 |
2.39 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-11-14 |
4 |
B |
$4.95 |
$4,950 |
D/D |
1,000 |
90,452 |
2.31 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
89,452 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-06-10 |
4 |
D |
$3.58 |
$5,026 |
D/D |
(1,404) |
81,952 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-05-13 |
4 |
B |
$3.50 |
$3,500 |
D/D |
1,000 |
83,356 |
2.31 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
72,966 |
72,966 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2015-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
9,390 |
58,027 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2014-11-10 |
4 |
D |
$9.49 |
$141,211 |
D/D |
(14,880) |
39,346 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2014-11-10 |
4 |
OE |
$4.64 |
$113,355 |
D/D |
24,430 |
54,226 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2014-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
9,291 |
39,087 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2014-03-06 |
4 |
OE |
$3.80 |
$87,085 |
D/D |
22,917 |
22,917 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
